In our recent webinar, Daniel Evans, Director of Business Development, joined industry partners to explore why Australia is a leading destination for clinical trials. The discussion highlighted the key advantages of conducting clinical trials in Australia, focusing on the country’s efficiency, cost-effectiveness, and high-quality standards.
Key Takeaways:
The session provided valuable insights into how these factors make Australia an attractive option for clinical trials.
Fill out the form below to watch the full session and learn how Australia’s regulatory environment can support your clinical development.
Simi Barretto
Marketing and Digital Media Manager
Southern Star Research
Location: Australia
Email: media@southernstarresearch.com
Tel: +61283501918
L1, 1 Merriwa Street,
Gordon, NSW, 2072 Australia
Connect with us
Keep up to date with the latest news, updates and promotions
"*" indicates required fields
Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.
By clicking 'SUBSCRIBE NOW', you agree that Southern Star Research may collect and use your personal data for these marketing and communication purposes.
Each member of our Leadership Team boasts an average of 30 years experience. Our clients have access to an extraordinary group of Clinical Research professionals, whose experience covers Multinational Pharmaceutical companies, Biotechnology, Medical Device, CRO’s, research institutes, Universities, Industry Associations & Government Bodies. Together, we ensure that every aspect of your unique and novel drug study clinical trial is handled with scientific precision, care, and foresight.
Our team has all of the tools, knowledge and experience to solve almost any issue that may arise during the complex clinical trial process.
We recognize that each study is unique and different and there are nuances that need to be resolved proactively.
Our advisory board of top-tier specialists in multiple therapeutic areas engage in the early stages from protocol design in constructive discussions to anticipate challenges and enhance study efficiency throughout the study.
